Black Diamond Therapeutics Inc

Healthcare · Biotechnology

1.90$ +1.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Black Diamond Therapeutics Inc (BDTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 125 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BDTX
Line item	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	–	–	52	40	40	81	158	363	349	346	330	313	288	274	248	219	199	180	156	136	120	172	159	143	150	138	123	176	166	158	143	133	125
Current Assets	–	–	–	52	52	40	79	156	362	208	336	320	297	271	242	216	188	169	151	128	108	93	147	134	119	127	116	101	156	147	139	132	123	115
Cash	–	–	–	52	-52	40	79	155	357	64	56	35	14	37	47	66	54	56	54	34	39	42	58	56	25	33	23	36	98	30	31	21	30	19
Cash & Short-Term Investments	–	–	–	52	52	40	79	155	357	204	333	315	290	263	235	210	180	161	144	123	103	90	144	131	115	123	113	99	152	143	136	129	118	111
Property, Plant & Equipment	–	–	–	0.1	0.1	0.1	0.1	0.2	0.6	0.5	8.7	8.8	0.8	16	31	31	30	29	28	2.6	2.3	2.3	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	–	–	–	67	11	1.5	4.6	205	7.5	6.3	19	22	33	37	55	52	47	46	47	41	37	38	38	42	38	39	40	39	35	34	32	31	29	29
Current Liabilities	–	–	–	2.6	1.5	1.5	4.6	4.9	7.3	6.1	11	14	19	23	26	24	19	20	21	15	13	14	15	20	17	18	21	21	17	17	16	16	15	16
Short-Term Debt	–	–	–	–	–	–	–	–	0.2	0.2	0.9	1.0	0.4	0.5	–	0.3	0.8	2.1	2.8	2.8	2.9	3.0	3.0	3.1	3.2	3.3	3.3	3.4	3.7	3.8	3.6	3.7	3.8	3.9
Accounts Payable	–	–	–	0.4	0.7	0.7	1.4	2.0	3.8	0.0	2.9	2.5	4.6	5.0	4.9	4.1	1.9	2.2	5.8	1.9	3.0	2.7	0.7	2.3	1.2	0.8	2.0	4.0	2.6	0.8	1.0	0.6	3.0	1.4
Shareholders' Equity	–	–	–	-16	45	29	76	-47	355	343	327	308	281	251	219	196	173	152	133	116	98	82	134	117	104	111	97	83	142	133	126	112	104	96
Retained Earnings	–	–	–	-16	-32	-32	-41	-51	-63	-78	-96	-118	-149	-183	-218	-244	-269	-292	-314	-335	-356	-375	-398	-417	-436	-456	-471	-487	-431	-441	-450	-465	-474	-484
Shares Outstanding	2.0	2.0	2.0	14	14	14	14	33	24	36	36	36	36	36	36	36	36	36	36	36	36	37	51	47	52	55	57	57	58	57	57	57	57	57

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings